Complexity of VEGF responses in skin carcinogenesis revealed through ex vivo assays based on a VEGF-A null mouse keratinocyte cell line

Journal of Investigative Dermatology

Volumn 129, Issue 3, 2009, Pages 730-741

  Mirones, Isabel ^a   Conti, Claudio J ^b   Martínez, Jesús ^a   Garcia, Marta ^a   Larcher, Fernando ^a,c  

^a Basic Research Department   (Spain)

^b UNIVERSITY OF TEXAS   (United States)

^c CIEMAT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CALCIUM; CRE RECOMBINASE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CLONE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; EX VIVO STUDY; IN VITRO GENE TRANSFER; IN VIVO STUDY; KERATINOCYTE; LOXP SITE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; SKIN CARCINOGENESIS;

ADENOVIRIDAE; ALLELES; ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELL LINE; GENE TRANSFER TECHNIQUES; KERATINOCYTES; MICE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RAS PROTEINS; SKIN; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 59949103716     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.292     Document Type: Article

References (63)

1. Adams DJ, van der Weyden L (2001) Are we creating problems? Negative effects of Cre recombinase. Genesis 29:115
2. Aldaz CM, Conti CJ, Yuspa SH, Slaga TJ (1988) Cytogenetic profile of mouse skin tumors induced by the viral Harvey-ras gene. Carcinogenesis 9:1503-5
3. Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E (1995) Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 104:7-10
4. Bolontrade MF, Stern MC, Binder RL, Zenklusen JC, Gimenez-Conti IB, Conti CJ (1998) Angiogenesis is an early event in the development of chemically induced skin tumors. Carcinogenesis 19:2107-13
5. Bradley MO, Kraynak AR, Storer RD, Gibbs JB (1986) Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes. Proc Natl Acad Sci USA 83:5277-81
6. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak A et al. (1997) Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 79:233-69
7. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF et al. (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:1375-9
8. Buerger A, Rozhitskaya O, Sherwood MC, Dorfman AL, Bisping E, Abel ED et al. (2006) Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail 12:392-8
9. Caldelari R, Suter MM, Baumann D, De Bruin A, Muller E (2000) Long-term culture of murine epidermal keratinocytes. J Invest Dermatol 114:1064-5
10. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-9
11. Casanova ML, Larcher F, Casanova B, Murillas R, Fernandez-Acenero MJ, Villanueva C et al. (2002) A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res 62:3402-7
12. Colburn NH, Vorder Bruegge WF, Bates JR, Gray RH, Rossen JD, Kelsey WH et al. (1978) Correlation of Anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res 38:624-34
13. Detmar M (2000a) The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci 24(Suppl 1):S78-S84
14. Detmar M (2000b) Tumor angiogenesis. J Investig Dermatol Symp Proc 5:20-3
15. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW et al. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-6
16. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L et al. (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111:1-6
17. Dodson MG, Slota J, Lange C, Major E (1981) Distinction of the phenotypes of in vitro anchorage-independent soft-agar growth and in vivo tumorigenicity in the nude mouse. Cancer Res 41:1441-6
18. Dong J, Grunstein J, Tejada M, Peale F, Frantz G, Liang WC et al. (2004) VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J 23:2800-10
19. Ferrara N (2000) VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 11:617-24
20. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-42
21. Garcia M, Fernandez-Garcia NI, Rivas V, Carretero M, Escamez MJ, Gonzalez-Martin A et al. (2004) Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Res 64:5632-42
22. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L et al. (1999) VEGF is required for growth and survival in neonatal mice. Development 126:1149-59
23. Goldaber ML, Kubilus J, Phillips SB, Henkle C, Atkins L, Baden HP (1990) Immortal clones of NM1 keratinocytes contain an isochromosome of the long arm of chromosome 8. In Vitro Cell Dev Biol 26:7-8
24. Hager B, Bickenbach JR, Fleckman P (1999) Long-term culture of murine epidermal keratinocytes. J Invest Dermatol 112:971-6
25. Hakkinen L, Koivisto L, Larjava H (2001) An improved method for culture of epidermal keratinocytes from newborn mouse skin. Methods Cell Sci 23:189-96
26. Hansen LA, Woodson RL II, Holbus S, Strain K, Lo YC, Yuspa SH (2000) The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. Cancer Res 60:3328-32
27. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH (1980) Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-54
28. Heyden A, Lützow-Holm C, Clausen OP, Brandtzaeg P, Huitfeldt HS (1995) Topical application of 12-O-tetradecanoylphorbol-13-acetate induces dyssynchronous expression of keratins K1 and K10 in mouse epidermis. Cytometry 19:313-9
29. Herynk MH, Zhang J, Parikh NU, Gallick GE (2007) Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells. J Exp Ther Oncol 6:205-17
30. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010-7
31. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089-99
32. Kinsella TM, Nolan GP (1996) Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 7:1405-13
33. Kong D, Li Y, Wang Z, Banerjee S, Sarkar FH (2007) Inhibition of angiogenesis and invasion by 3,3′-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 67:3310-9
34. Larcher F, Del Rio M, Serrano F, Segovia JC, Ramirez A, Meana A et al. (2001) A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts. FASEB J 15:1529-38
35. Larcher F, Franco M, Bolontrade M, Rodriguez-Puebla M, Casanova L, Navarro M et al. (2003) Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis. Mol Carcinog 37:83-90
36. Larcher F, Murillas R, Bolontrade M, Conti CJ, Jorcano JL (1998) VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 17:303-11
37. Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A et al. (1996) Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated Hras expression levels. Cancer Res 56:5391-6
38. Lawler J, Detmar M (2004) Tumor progression: the effects of thrombospondin-1 and -2. Int J Biochem Cell Biol 36:1038-45
39. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S et al. (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130:691-703
40. Lin AW, Lowe SW (2001) Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc Natl Acad Sci USA 98:5025-30
41. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R et al. (2001) Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98:9209-14
42. Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG (2007) Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96:1092-100
43. Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L et al. (2002) Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 115:2559-67
44. Ouellet T, Lussier M, Babaï F, Lapointe L, Royal A (1990) Differential expression of the epidermal K1 and K10 keratin genes during mouse embryo development. Biochem Cell Biol 68:448-53
45. Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F (1993) Chromosome analysis of 20 breast carcinomas: cytogenetic multi-clonality and karyotypic-pathologic correlations. Genes Chromosomes Cancer 6:51-7
46. Rak J, Kerbel RS (2001) Ras regulation of vascular endothelial growth factor and angiogenesis. Methods Enzymol 333:267-83
47. Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-43
48. Rho O, Beltran LM, Gimenez-Conti IB, DiGiovanni J (1994) Altered expression of the epidermal growth factor receptor and transforming growth factor-alpha during multistage skin carcinogenesis in SENCAR mice. Mol Carcinog 11:19-28
49. Rice RH, Steinmann KE, deGraffenried LA, Qin Q, Taylor N, Schlegel R (1993) Elevation of cell cycle control proteins during spontaneous immortalization of human keratinocytes. Mol Biol Cell 4:185-94
50. Roop DR, Hawley-Nelson P, Cheng CK, Yuspa SH (1983) Expression of keratin genes in mouse epidermis and normal and malignantly transformed epidermal cells in culture. J Invest Dermatol 81:144s-9s
51. Rossiter H, Barresi C, Pammer J, Rendl M, Haigh J, Wagner EF et al. (2004) Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation. Cancer Res 64:3508-16
52. Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR (2000) Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97:13702-7
53. Segrelles C, Ruiz S, Perez P, Murga C, Santos M, Budunova IV et al. (2002) Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 21:53-64
54. Silver DP, Livingston DM (2001) Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8:233-43
55. Streit M, Stephen AE, Hawighorst T, Matsuda K, Lange-Asschenfeldt B, Brown LF et al. (2002) Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. Cancer Res 62:2004-12
56. Strickland JE, Greenhalgh DA, Koceva-Chyla A, Hennings H, Restrepo C, Balaschak M et al. (1988) Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 48:165-9
57. Thurston G, Murphy TJ, Baluk P, Lindsey R, McDonald DM (1998) Angiogenesis in mice with chronic airway inflammation. Am J Pathol 153:1099-112
58. Ueda M, Kawamura H, Sutter C, Glick A, Yuspa SH, Strickland JE (1995) Analysis of v-Ha-ras and v-fos oncogene transduction into a mouse epidermal cell line with "initiated" phenotype in culture but normal skin phenotype in vivo. Mol Carcinog 13:96-103
59. Viloria-Petit A, Miquerol L, Yu JL, Gertsenstein M, Sheehan C, May L et al. (2003) Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors. EMBO J 22:4091-102
60. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324:1-8
61. Weninger W, Uthman A, Pammer J, Pichler A, Ballaun C, Lang IM et al. (1996) Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest 75:647-57
62. Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R et al. (2005) Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 167:1257-66
63. Yang S, Delgado R, King SR, Woffendin C, Barker CS, Yang ZY et al. (1999) Generation of retroviral vector for clinical studies using transient transfection. Hum Gene Ther 10:123-32